danazol has been researched along with Cancer, Second Primary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abd Alsamad, I; Degos, F; Laraki, R | 1 |
| Lorber, M; Pollack, S; Shahar, A; Sharon, R | 1 |
2 other study(ies) available for danazol and Cancer, Second Primary
| Article | Year |
|---|---|
[Anatomo-clinical conference. Pitié-Salpêtrière Hospital. Case N.1-1994. Multiple hepatic tumors in a woman with idiopathic thrombopenic purpura].
Topics: Adenoma, Liver Cell; Adult; Colchicine; Danazol; Facial Neoplasms; Female; Humans; Liver Neoplasms; Melanoma; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Purpura, Thrombocytopenic, Idiopathic; Skin Neoplasms | 1994 |
[Angioedema caused by splenectomy with malignant lymphoma followed by multiple myeloma 7 years later].
Topics: Angioedema; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Complement C1 Inactivator Proteins; Danazol; Estrogen Antagonists; Female; Humans; Immunoglobulin A; Lymphoma, Non-Hodgkin; Middle Aged; Multiple Myeloma; Neoplasms, Second Primary; Postoperative Complications; Spleen; Splenectomy | 1997 |